Moreover, in the study, we discovered that combining different classes of drugs targeting significant components of cholesterol metabolism, namely (1) HMG-CoA reductase, (2) MTTP, or (3) intestinal ACAT, along with blocking the impact of oxidative stress, made it possible to control the development and progression of atherosclerosis in the proposed model. Here, HMGCR is linked to atherosclerosis.